Cartesian Therapeutics Announces New Employment Inducement GrantsBusiness Wire • about 2 months agoCartesian Therapeutics, Inc. (NASDAQ: RNAC) (the Company), a clinical-stage biotechnology company developing mRNA cell therapies for the treatment of autoimmune diseases, today announced the granting...